These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anti-melanogenesis potential of a new series of Morita-Baylis-Hillman adducts in B16F10 melanoma cell line. Ketata E; Elleuch H; Neifar A; Mihoubi W; Ayadi W; Marrakchi N; Rezgui F; Gargouri A Bioorg Chem; 2019 Mar; 84():17-23. PubMed ID: 30476649 [TBL] [Abstract][Full Text] [Related]
23. Highly potent anti-melanogenic effect of 2-thiobenzothiazole derivatives through nanomolar tyrosinase activity inhibition. Jin Jung H; Jin Kim H; Soo Park H; Young Kim G; Jung Park Y; Lee J; Kyung Kang M; Yoon D; Kang D; Park Y; Chun P; Young Chung H; Ryong Moon H Bioorg Chem; 2024 Sep; 150():107586. PubMed ID: 38955001 [TBL] [Abstract][Full Text] [Related]
25. Thiazol-4(5H)-one analogs as potent tyrosinase inhibitors: Synthesis, tyrosinase inhibition, antimelanogenic effect, antioxidant activity, and in silico docking simulation. Jung Park Y; Jin Jung H; Jin Kim H; Soo Park H; Lee J; Yoon D; Kyung Kang M; Young Kim G; Ullah S; Kang D; Park Y; Chun P; Young Chung H; Ryong Moon H Bioorg Med Chem; 2024 Jan; 98():117578. PubMed ID: 38154348 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and anti-tyrosinase mechanism of the substituted vanillyl cinnamate analogues. Zhao Z; Liu G; Meng Y; Tian J; Chen X; Shen M; Li Y; Li B; Gao C; Wu S; Li C; He X; Jiang R; Qian M; Zheng X Bioorg Chem; 2019 Dec; 93():103316. PubMed ID: 31585271 [TBL] [Abstract][Full Text] [Related]
27. Exploring 2-mercapto- Jung HJ; Park HS; Kim HJ; Park HS; Kim YE; Jeong DE; Noh SG; Park Y; Chun P; Chung HY; Moon HR Org Biomol Chem; 2024 Sep; 22(37):7671-7689. PubMed ID: 39222053 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers. Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952 [TBL] [Abstract][Full Text] [Related]
29. Exploration of Compounds with 2-Phenylbenzo[ Jung HJ; Park HS; Park HS; Kim HJ; Yoon D; Park Y; Chun P; Chung HY; Moon HR Molecules; 2024 Sep; 29(17):. PubMed ID: 39275009 [TBL] [Abstract][Full Text] [Related]
30. Coumaric acid derivatives as tyrosinase inhibitors: Efficacy studies through in silico, in vitro and ex vivo approaches. Varela MT; Ferrarini M; Mercaldi VG; Sufi BDS; Padovani G; Nazato LIS; Fernandes JPS Bioorg Chem; 2020 Oct; 103():104108. PubMed ID: 32750608 [TBL] [Abstract][Full Text] [Related]
31. The tyrosinase inhibitory effects of isoxazolone derivatives with a (Z)-β-phenyl-α, β-unsaturated carbonyl scaffold. Kim SJ; Yang J; Lee S; Park C; Kang D; Akter J; Ullah S; Kim YJ; Chun P; Moon HR Bioorg Med Chem; 2018 Aug; 26(14):3882-3889. PubMed ID: 29907470 [TBL] [Abstract][Full Text] [Related]
33. Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities. Iraji A; Khoshneviszadeh M; Bakhshizadeh P; Edraki N; Khoshneviszadeh M Med Chem; 2020; 16(7):892-902. PubMed ID: 31339074 [TBL] [Abstract][Full Text] [Related]
34. Inhibitory properties of aromatic thiosemicarbazones on mushroom tyrosinase: Synthesis, kinetic studies, molecular docking and effectiveness in melanogenesis inhibition. Hałdys K; Goldeman W; Jewgiński M; Wolińska E; Anger N; Rossowska J; Latajka R Bioorg Chem; 2018 Dec; 81():577-586. PubMed ID: 30248509 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, molecular docking, dynamic simulations, kinetic mechanism, cytotoxicity evaluation of N-(substituted-phenyl)-4-{(4-[(E)-3-phenyl-2-propenyl]-1-piperazinyl} butanamides as tyrosinase and melanin inhibitors: In vitro, in vivo and in silico approaches. Raza H; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Hassan M; Abbas Q; Hong H; Shah SAA; Shahid M; Seo SY Bioorg Chem; 2020 Jan; 94():103445. PubMed ID: 31826809 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Antimelanogenic Activity and Mechanism of Galangin in Silico and in Vivo. Chung KW; Jeong HO; Lee EK; Kim SJ; Chun P; Chung HY; Moon HR Biol Pharm Bull; 2018; 41(1):73-79. PubMed ID: 29311485 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase. Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of tyrosinase activity and melanin production by the chalcone derivative 1-(2-cyclohexylmethoxy-6-hydroxy-phenyl)-3-(4-hydroxymethyl-phenyl)-propenone. Kim BH; Park KC; Park JH; Lee CG; Ye SK; Park JY Biochem Biophys Res Commun; 2016 Nov; 480(4):648-654. PubMed ID: 27983977 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and evaluation of (E)-N-substituted benzylidene-aniline derivatives as tyrosinase inhibitors. Bae SJ; Ha YM; Park YJ; Park JY; Song YM; Ha TK; Chun P; Moon HR; Chung HY Eur J Med Chem; 2012 Nov; 57():383-90. PubMed ID: 23149255 [TBL] [Abstract][Full Text] [Related]